News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
We are pleased to introduce Chris Smyth, Group CEO of Comac Medical, through this three-part in-depth interview series....
[Sofia, Bulgaria] – Recycling at our HQ matters. Every item disposed of correctly helps us reduce waste and use...
In today’s fast-evolving biotech landscape, choosing the right biotech CRO (Contract Research Organization) can be the single most...